Location History:
- Zhengzhou, CN (2016)
- Beijing, CN (2019)
Company Filing History:
Years Active: 2016-2019
Title: Haoyun An: Innovator in Pharmaceutical Chemistry
Introduction
Haoyun An is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. With a total of two patents to his name, An's work focuses on innovative solutions for treating diseases.
Latest Patents
Haoyun An's latest patents include a urea peptoid boric acid compound and a pharmaceutical composition thereof. This invention provides a urea peptidomimetic boronic compound along with its preparative methods and uses. The compounds are represented by a specific formula, showcasing their potential in medical applications. Another notable patent involves pyrimidine nucleoside derivatives, which includes synthesis methods and uses for preparing anti-tumor and anti-virus medicaments. This invention relates to pharmacochemistry and discloses fluorinated and azido-substituted pyrimidine nucleoside derivatives. These compounds can be utilized for treating diseases such as tumors and viral infections, demonstrating effective activity with minimal side effects.
Career Highlights
Throughout his career, Haoyun An has worked with several reputable organizations. He has been associated with Zhengzhou Granlen Pharmatech Ltd. and the High & New Technology Research Center at the Henan Academy of Sciences. His experience in these institutions has contributed to his expertise in pharmaceutical innovations.
Collaborations
Haoyun An has collaborated with notable colleagues, including Junbiao Chang and Xuejun Yu. These partnerships have likely enhanced his research and development efforts in the pharmaceutical field.
Conclusion
Haoyun An is a distinguished inventor whose work in pharmaceutical chemistry has the potential to impact the treatment of various diseases. His innovative patents reflect his commitment to advancing medical science and improving patient outcomes.